Popular Articles

Some Governors Oppose Medicaid Expansion Proposals
"Some governors are pushing to scale back or kill proposals to expand Medicaid to provide health-care coverage to the uninsured, raising a new challenge to President Barack Obama"s effort to overhaul the system," The Wall Street Journal reports. Health care proposals in the House and Senate "would expand the program to cover at least a third of the nation"s 46 million uninsured, but states are worried they would get stuck with a big part of the tab." Medicaid is "expected to be a primary topic" when a group of governors -- "including Democratic Gov. Christine Gregoire of Washington and Republican Gov. Haley Barbour of Mississippi" -- head to Washington, D.C., this week "to discuss health care with White House and congressional officials."
generic viagra online
What Should A Teenage Girl Do If She Finds A Lump In Her Breast?
If a lump is found in the breast of an adolescent girl, she often will undergo an excisional biopsy.
News of the day
ARYx Therapeutics Inc. Updates Progress With Tecarfarin EmbraceAC Study
ARYx Therapeutics Inc. (NASDAQ:ARYX), a biopharmaceutical company, announced today that the database for the EmbraceAC study has been locked and the study remains on schedule, with the efficacy and safety results to be available during the week of July 6, 2009. The study was designed to compare its oral anticoagulation therapy, tecarfarin (previously ATI-5923), against the leading anticoagulant agent, warfarin. The purpose of the trial is to evaluate whether tecarfarin is superior to warfarin in its ability to maintain patients within a target therapeutic range of the level of anticoagulation as measured by INR (International Normalized Ratio). Based upon recent interactions with the U. S. Food and Drug Administration (FDA), ARYx believes this trial could be positioned as one of the required registration studies for tecarfarin.
Sexual Health

Common Migraine Pain Condition Also Prevalent In Cluster Headache

A pain condition common in people with migraines also has a high prevalence in patients with cluster headache, according to a study conducted by researchers at the Jefferson Headache Center at Jefferson Hospital for Neuroscience. Approximately half of a group of patients with cluster headaches experienced cutaneous allodynia, a condition that causes patients to have pain as a response to normally inconspicuous sensations, according to Michael Marmura, M.D., assistant professor of Neurology at Jefferson Medical College of Thomas Jefferson University. The study, which was published in the Journal of Headache and Pain, included 41 patients with either chronic or episodic cluster headaches. The researchers tested for allodynia by brushing a gauze pad over the forehead, neck and forearms. Patients then reported if the gauze was painful or unpleasant, or not. Twenty of the patients experienced allodynia, with the most common site of pain being the forehead. There were no significant differences between patients who experienced allodynia and patients who did not. The majority of patients were using preventive medications, which is a limitation of the study. According to Dr. Marmura, allodynia has typically been described in migraines, but this is the largest study to date showing that allodynia occurs in cluster headache. "It was surprising to find that allodynia was so common in patients with cluster headaches," Dr. Marmura said. "This could have important treatment implications, and suggests that there may be overlap in mechanisms for pain between migraines and cluster headaches." Thomas Jefferson University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):